358 related articles for article (PubMed ID: 33037071)
1. CDKN2A/p16INK4a suppresses hepatic fatty acid oxidation through the AMPKα2-SIRT1-PPARα signaling pathway.
Deleye Y; Cotte AK; Hannou SA; Hennuyer N; Bernard L; Derudas B; Caron S; Legry V; Vallez E; Dorchies E; Martin N; Lancel S; Annicotte JS; Bantubungi K; Pourtier A; Raverdy V; Pattou F; Lefebvre P; Abbadie C; Staels B; Haas JT; Paumelle R
J Biol Chem; 2020 Dec; 295(50):17310-17322. PubMed ID: 33037071
[TBL] [Abstract][Full Text] [Related]
2. LB100 ameliorates nonalcoholic fatty liver disease
Chen XY; Cai CZ; Yu ML; Feng ZM; Zhang YW; Liu PH; Zeng H; Yu CH
World J Gastroenterol; 2019 Dec; 25(45):6607-6618. PubMed ID: 31832001
[TBL] [Abstract][Full Text] [Related]
3. Reversal of diet-induced hepatic steatosis by peripheral CB1 receptor blockade in mice is p53/miRNA-22/SIRT1/PPARα dependent.
Azar S; Udi S; Drori A; Hadar R; Nemirovski A; Vemuri KV; Miller M; Sherill-Rofe D; Arad Y; Gur-Wahnon D; Li X; Makriyannis A; Ben-Zvi D; Tabach Y; Ben-Dov IZ; Tam J
Mol Metab; 2020 Dec; 42():101087. PubMed ID: 32987186
[TBL] [Abstract][Full Text] [Related]
4. SIRT4 represses peroxisome proliferator-activated receptor α activity to suppress hepatic fat oxidation.
Laurent G; de Boer VC; Finley LW; Sweeney M; Lu H; Schug TT; Cen Y; Jeong SM; Li X; Sauve AA; Haigis MC
Mol Cell Biol; 2013 Nov; 33(22):4552-61. PubMed ID: 24043310
[TBL] [Abstract][Full Text] [Related]
5. Lycopene and apo-10'-lycopenoic acid have differential mechanisms of protection against hepatic steatosis in β-carotene-9',10'-oxygenase knockout male mice.
Ip BC; Liu C; Lichtenstein AH; von Lintig J; Wang XD
J Nutr; 2015 Feb; 145(2):268-76. PubMed ID: 25644347
[TBL] [Abstract][Full Text] [Related]
6. The PPARβ/δ activator GW501516 prevents the down-regulation of AMPK caused by a high-fat diet in liver and amplifies the PGC-1α-Lipin 1-PPARα pathway leading to increased fatty acid oxidation.
Barroso E; Rodríguez-Calvo R; Serrano-Marco L; Astudillo AM; Balsinde J; Palomer X; Vázquez-Carrera M
Endocrinology; 2011 May; 152(5):1848-59. PubMed ID: 21363937
[TBL] [Abstract][Full Text] [Related]
7. Fasting-induced JMJD3 histone demethylase epigenetically activates mitochondrial fatty acid β-oxidation.
Seok S; Kim YC; Byun S; Choi S; Xiao Z; Iwamori N; Zhang Y; Wang C; Ma J; Ge K; Kemper B; Kemper JK
J Clin Invest; 2018 Jul; 128(7):3144-3159. PubMed ID: 29911994
[TBL] [Abstract][Full Text] [Related]
8. The diabetes medication canagliflozin promotes mitochondrial remodelling of adipocyte via the AMPK-Sirt1-Pgc-1α signalling pathway.
Yang X; Liu Q; Li Y; Tang Q; Wu T; Chen L; Pu S; Zhao Y; Zhang G; Huang C; Zhang J; Zhang Z; Huang Y; Zou M; Shi X; Jiang W; Wang R; He J
Adipocyte; 2020 Dec; 9(1):484-494. PubMed ID: 32835596
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia via ERK Signaling Inhibits Hepatic PPARα to Promote Fatty Liver.
Mooli RGR; Rodriguez J; Takahashi S; Solanki S; Gonzalez FJ; Ramakrishnan SK; Shah YM
Cell Mol Gastroenterol Hepatol; 2021; 12(2):585-597. PubMed ID: 33798787
[TBL] [Abstract][Full Text] [Related]
10. Sodium butyrate alleviates free fatty acid-induced steatosis in primary chicken hepatocytes via the AMPK/PPARα pathway.
Ding J; Liu J; Chen J; Cheng X; Cao H; Guo X; Hu G; Zhuang Y
Poult Sci; 2024 Apr; 103(4):103482. PubMed ID: 38387286
[TBL] [Abstract][Full Text] [Related]
11. Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation.
Purushotham A; Schug TT; Xu Q; Surapureddi S; Guo X; Li X
Cell Metab; 2009 Apr; 9(4):327-38. PubMed ID: 19356714
[TBL] [Abstract][Full Text] [Related]
12. A conjugated fatty acid present at high levels in bitter melon seed favorably affects lipid metabolism in hepatocytes by increasing NAD(+)/NADH ratio and activating PPARα, AMPK and SIRT1 signaling pathway.
Chen GC; Su HM; Lin YS; Tsou PY; Chyuan JH; Chao PM
J Nutr Biochem; 2016 Jul; 33():28-35. PubMed ID: 27260465
[TBL] [Abstract][Full Text] [Related]
13. SIRT1 performs a balancing act on the tight-rope toward longevity.
Purushotham A; Schug TT; Li X
Aging (Albany NY); 2009 Jul; 1(7):669-73. PubMed ID: 20157548
[TBL] [Abstract][Full Text] [Related]
14. Nordihydroguaiaretic acid improves metabolic dysregulation and aberrant hepatic lipid metabolism in mice by both PPARα-dependent and -independent pathways.
Zhang H; Shen WJ; Cortez Y; Kraemer FB; Azhar S
Am J Physiol Gastrointest Liver Physiol; 2013 Jan; 304(1):G72-86. PubMed ID: 23104557
[TBL] [Abstract][Full Text] [Related]
15. Hepatocyte Peroxisome Proliferator-Activated Receptor α Enhances Liver Regeneration after Partial Hepatectomy in Mice.
Xie G; Yin S; Zhang Z; Qi D; Wang X; Kim D; Yagai T; Brocker CN; Wang Y; Gonzalez FJ; Wang H; Qu A
Am J Pathol; 2019 Feb; 189(2):272-282. PubMed ID: 30448405
[TBL] [Abstract][Full Text] [Related]
16. Fisetin Protects Against Hepatic Steatosis Through Regulation of the Sirt1/AMPK and Fatty Acid β-Oxidation Signaling Pathway in High-Fat Diet-Induced Obese Mice.
Liou CJ; Wei CH; Chen YL; Cheng CY; Wang CL; Huang WC
Cell Physiol Biochem; 2018; 49(5):1870-1884. PubMed ID: 30235452
[TBL] [Abstract][Full Text] [Related]
17. Gα12 ablation exacerbates liver steatosis and obesity by suppressing USP22/SIRT1-regulated mitochondrial respiration.
Kim TH; Yang YM; Han CY; Koo JH; Oh H; Kim SS; You BH; Choi YH; Park TS; Lee CH; Kurose H; Noureddin M; Seki E; Wan YY; Choi CS; Kim SG
J Clin Invest; 2018 Dec; 128(12):5587-5602. PubMed ID: 30300140
[TBL] [Abstract][Full Text] [Related]
18. Farnesol induces fatty acid oxidation and decreases triglyceride accumulation in steatotic HepaRG cells.
Pant A; Rondini EA; Kocarek TA
Toxicol Appl Pharmacol; 2019 Feb; 365():61-70. PubMed ID: 30611723
[TBL] [Abstract][Full Text] [Related]
19. Perfluoroalkyl acids-induced liver steatosis: Effects on genes controlling lipid homeostasis.
Das KP; Wood CR; Lin MT; Starkov AA; Lau C; Wallace KB; Corton JC; Abbott BD
Toxicology; 2017 Mar; 378():37-52. PubMed ID: 28049043
[TBL] [Abstract][Full Text] [Related]
20. PARP1-mediated PPARα poly(ADP-ribosyl)ation suppresses fatty acid oxidation in non-alcoholic fatty liver disease.
Huang K; Du M; Tan X; Yang L; Li X; Jiang Y; Wang C; Zhang F; Zhu F; Cheng M; Yang Q; Yu L; Wang L; Huang D; Huang K
J Hepatol; 2017 May; 66(5):962-977. PubMed ID: 27979751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]